Searched for
CHLORPHENIRAMINE
Under the scanner, yet generic cough syrups hit shelvesWorry is spreading regarding the multitude of cough syrup brands circulating in India, with alarming revelations of toxic diethylene glycol...
Maharashtra FDA flags Coldrif syrup batch linked to child deathsMaharashtra FDA urged people to stop using Coldrif syrup batch SR-13. This follows child deaths in Madhya Pradesh and Rajasthan. Tamil Nadu...
Maharashtra bans Coldrif cough syrup batch over safety concernsThe Maharashtra Food and Drug Administration (FDA) on Sunday ordered an immediate halt to the sale, distribution, and use of Coldrif cough ...
For the kids' sake, target grown-upsGovernment bans on cough syrups for young children and energy drinks for minors are positive steps, but effective implementation requires m...
Relief for pharma cos as Delhi HC says cough syrup ban applies prospectivelyThe Delhi High Court has provided relief to pharma companies like Glenmark Pharmaceuticals and Zuventus Healthcare, ruling that the ban on ...
Pharmacists seek clarity on banned cough syrup stockPharmacists are seeking clarification from the DCGI regarding the handling of recently banned cough syrups for children under four, specifi...
Govt bans select cough syrups for kids below 4 yearsThe government has prohibited cough syrups containing chlorpheniramine maleate and phenylephrine hydrochloride for children under four due ...
Govt bans 156 medicines including antibiotics, painkillers, multivitamins: Here is the full listThe Ministry of Health and Family Welfare has banned the manufacture, sale, and distribution of 156 fixed dose combinations. These include ...
Central drug regulator cracks down on FDCsIn 2012, a parliamentary standing committee of the health ministry had observed in its report that some of the state licensing authorities ...
Centre bans anti-cold fixed drug combination for under-four childrenIn a letter dated December 18, the drug regulator said that FDC (fixed-dose combination) chlorpheniramine maleate and phenylephrine should ...
Govt bans anti-cold fixed drug combination for under-four childrenThe matter was deliberated in the Subject Expert Committee (SEC- Pulmonary) meeting held on June 6. "The committee recommended that the FDC...
Supriya Lifescience to bet on R&D, expansion to grow revenuesSupriya Lifescience, an active pharmaceutical ingredient (API) maker based in Mumbai, aims to double its revenue in the next three years. T...
India bans 14 fixed-dose medicines for likely posing risks to healthThe Indian government has banned 14 types of fixed-dose combination (FDC) medicines due to a lack of therapeutic justification and potentia...
Govt bans 14 fixed dose combination drugs, cites they may involve risk to peopleThe expert committee said that there is "no therapeutic justification for this FDC (fixed dose combination) and the FDC may involve risk to...
Surge in viral infections pushes up pharma salesThe volumes were tepid in January, but with flu, Covid-19 and other viral infections spreading fast, February and March saw spikes in volum...
Cough syrup causes baby boy to stop breathing for 17 minutes, Mumbai family races against time to bring him back from the brink of deathProceed with caution when it comes to cough syrups.
Supriya Lifescience lists at 55% premium over issue priceThe Rs 700 crore-IPO by the API manufacturer was sold from December 16 to 20 and was subscribed nearly 72 times, with the IPO getting fully...
Supriya Lifescience IPO opens: Here's what brokerages are suggestingA day before the IPO, Supriya Lifesciences raised Rs 315 crore from 18 anchor investors, allocating them 1,14,96,351 equity shares for Rs 2...
Supriya Lifescience a good bet on healthy growth, valuationsActive pharmaceutical ingredient (API) manufacturer Supriya Lifescience has a niche basket of 38 APIs across therapeutic segments and it ea...
Supriya Lifescience files DRHP to raise Rs 1,200 crore via IPOThe IPO consists of a fresh issue of shares worth Rs 200 crore and an offer of sale (OFS) of shares worth up to Rs 1,000 crore held by its ...